Collagen peptide supplement around knee replacement surgery for knee osteoarthritis
Tests a collagen supplement versus placebo in people having knee replacement for osteoarthritis.
Key facts
- Who runs it
- University of Arkansas
- Where
- Little Rock, United StatesSee the site
- Trial code
- Registry title
- Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing After Total Knee Arthroplasty (TKA)
- Status
- Recruiting
- People taking part
- 44 people, planned
- Started
- 1 May 2026
- Expected to end
- 1 Jun 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- SOLUGEL
- Placebo
- Record updated
- 27 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with primary knee osteoarthritis who are scheduled for a total knee replacement (TKA) at UAMS. It tests a collagen peptide supplement against a placebo.
- Age
- 50 to 75 years old
- Sex
- Men and women. Women must be postmenopausal.
- Disease stage
- Primary osteoarthritis, with a total knee replacement scheduled at UAMS two months before surgery.
- Earlier treatment
- No hormone replacement therapy in the last 12 months. No earlier surgery to the ACL in the knee being replaced.
- Biomarker or test result
- Body mass index of 20.0 to 39.9 kg/m2. COVID-19 negative and/or no symptoms.
Main reasons for not taking part
- Earlier serious injury to the knee being replaced, or ACL surgery in that knee
- Women who are not postmenopausal
- Hormone replacement therapy in the last 12 months
- Active blood-borne infectious disease
- Living away from Little Rock or not going to physical therapy in Little Rock
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Males and Females, 50 to 75 years old
- With a body mass index of 20.0 to 39.9 kg/m2
- Diagnosed with primary osteoarthritis
- Scheduled for a TKA at UAMS (two months prior to surgery) at UAMS
- Live near Little Rock and scheduled to attend physical therapy in Little Rock
- COVID-19 negative and/or asymptomatic
Who cannot take part
- Previously sustained serious knee injury or surgery to ACL in TKA knee
- Having undergone hormone replacement therapy in the last 12 months
- Active diagnosis of blood borne infectious disease
- Females not postmenopausal
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 50 and 75 years old?
Where in United States
- University of Arkansas for Medical SciencesLittle Rock, United StatesContact: Shiloah Kviatkovsky, PhDTaking people
About the trial
What the trial wants to find out
Recruiting will be performed via checking the calendar for scheduled TKA procedures in the > 8 weeks by clinical staff in the UAMS orthopedic clinic. Clinic staff will look for basic inclusion/exclusion criteria in the EMR for those patients. Clinic staff will either contact directly or send contact information to the PI of this study to contact for recruitment purposes. During the initial phone call, study staff will review inclusion/exclusion criteria to verify eligibility and will discuss study specifics and send a link to the current informed consent form located on the UAMS REDCap server. If the subject wishes to enroll, they will do so via electronic consent through REDCap. REDCap will notify study staff that the consent was signed, then study staff will schedule initial baseline study visit.
Read full original descriptionShow less
Visit 1 and Visit 2 will take place at the RIOA at week 0 and week 24, respectively. Participants will report having fasted overnight, and having abstained from alcohol for 24 hours, vigorous exercise for 24 hours, and caffeine for 12 hours. A blood sample will be drawn upon arrival, followed by a DXA scan to measured bone mineral density (BMD) in both hips and lumbar spine, and for body composition, using CTRAL equipment. Participants will also undergo a body water assessment using BIA to determine deuterium dose. Bilateral handgrip strength will be measured via Dynamometer. Participants will fill out a 3-Day food log, physical activity questionnaire, pain scale, KOOS, VR-12, and the POMS. Participants will be given an 8-week supply of their respective treatment supplement, with instructions and a compliance log (to be filled out monthly). Participants will also be given their dose of deuterium oxide (D2O) to be ingested according to instruction at week 2\&3, prior to TKA (week 4).
Tissue samples for ACL, bone fragments, and synovial fluid will be collected by the PI during TKA surgery. All other assessments will be taken during clinical visits with the participant's physical therapists and their orthopedic doctors. The PI will attend some of these visits to assess wound healing, administer handgrip strength assessment, and to replenish participant treatment supply.
The 2 groups in the trial
- Collagen PeptidesTreatment being tested
10 grams per day for 24 weeks
Treatment: SOLUGEL
- PlaceboPlacebo, for comparison
10 grams per day maltodextrin for 24 weeks
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing After Total Knee Arthroplasty (TKA)
- Plain-language title
- Collagen peptide supplement around knee replacement surgery for knee osteoarthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT05823727, who can take part
- Record updated
- 27 May 2026